Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

The REGAIN Study Group

    Research output: Contribution to journalComment/debatepeer-review

    Abstract

    The article “Eculizumab improves fatigue in refractory generalized myasthenia gravis”, written by “Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O’Brien, Kaushik Patra, James F. Howard Jr. and The REGAIN Study Group” was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 23 March 2019 without open access.

    Original languageEnglish
    Pages (from-to)2255
    Number of pages1
    JournalQuality of Life Research
    Volume28
    Issue number8
    DOIs
    Publication statusPublished - 2019 Aug 15

    Bibliographical note

    Publisher Copyright:
    © 2019, The Author(s).

    ASJC Scopus subject areas

    • Public Health, Environmental and Occupational Health

    Fingerprint

    Dive into the research topics of 'Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)'. Together they form a unique fingerprint.

    Cite this